2023-04-18 09:10:01 ET
- Monaghan Medical Corporation (Monaghan) and Premier ( NASDAQ: PINC ) on Tuesday have signed a three-year contract, effective May 1, 2023, creating a partnership between two healthcare industry leaders.
- Per the terms, Monaghan will provide Premier AscenDrive Program members with respiratory devices in two categories: Respiratory Therapy Medication Delivery devices and Oscillatory Positive Expiratory Pressure/Positive Airway Pressure devices.
- The pact recognizes the value of Monaghan’s medical devices in treating COPD, asthma, and respiratory illness and acknowledges Monaghan’s reputation for both industry-leading technology and proven clinical outcomes.
- The move will also leverage Premier’s robust tools and services to measure and improve the cost and quality of care.
For further details see:
Premier, Monaghan Medical inks AscenDrive contract